Psychopharmacology of imipramine and desipramine: A comparative study of their effects in normal males
- 37 Downloads
The effects of imipramine and desipramine were each examined at three dose levels in normal males. A placebo-controlled, double-blind procedure was employed. Effects were measured in a variety of behavioral and subjective responses. The resulting drug-action profiles reveal that imipramine produced hypnotic-like actions, as evidenced by the observation — and subjective reports — of marked sleepiness and concomitant impairment of intelectual and visuo-motor functioning. Side-effects of a cardiovascular, gastrointestinal disturbing, or anticholinergiclike nature were often experienced.
In contrast, desipramine produced effects in only two of the areas measured — a slight increase in sleepiness and a rise in pulse rate. The increased sleepiness was not accompanied by self-reports of a generalized impairment of performance, nor by actual decrements in performance measures. The side-effects reported were few in number and minimal in degree.
For both drugs the effects were dose related, maximal 2 1/2 hours after ingestion, and had subsided within 7 hours. The relationship of these effects to chemostructural variations, to clinical applications, and to possible modes of action of the two drugs were discussed.
Unable to display preview. Download preview PDF.
- Ban, T. A., and H. E. Lehmann: Clinical trial with desmethylimipramine, a new antidepressant compound. Canad. med. Ass. J. 86, 1030–1031 (1962).Google Scholar
- Brodie, B., P. Dick, P. Kielholz, W. Poldinger, and W. Theobald: Preliminary pharmacological and clinical results with desmethylimipramine, a metabolite of imipramine. Psychopharmacologia (Berl.) 2, 467–474 (1961).Google Scholar
- Denber, H. C. B.: Chlorpromazine-diethazine in the treatment of depression. Dis. nerv. Syst. (Monograph Suppl.) 18 (7), 1–4 (1957).Google Scholar
- Dimascio, A., L. Havens, and G. Klerman: The psychopharmacology of phenothiazine compounds: A comparative study of the effects of chlorpromazine, promethazine, trifluoperazine, and perphenazine in normal males. J. nerv. ment. Dis. 136 (1), 15–28; 136 (2), 168–186 (1963)Google Scholar
- Domenjoz, R., u. W. Theobald: Zur Pharmakologie des Tofranil (N-(3-Dimethylaminopropyl)-iminodibenzylhydrochlorid). Arch. int. Pharmacodyn. 120, 450–489 (1959).Google Scholar
- Flach, F. F., and P. F. Regan: Chemotherapy in emotional disorders. New York: McGraw-Hill Book Co. 1960.Google Scholar
- Frommel, E., C. Fleury, et J. Schmidt-Genzkey: De l'action psychoanaleptique du Tofranil. Schweiz. med. Wschr. 90, 830 (1960).Google Scholar
- Hill, R. T., I. Koosis, M. W. Minor, and E. B. Sigg: The potentiation of methylphenidate by imipramine, amitriptyline and their desmethyl analogues. Pharmacologist 3, 75 (1961).Google Scholar
- Hollister, L. E., J. E. Overall, J. Shelton, M. Johnson, G. Katz, and V. Pennington: Controlled study of desipramine in depression. J. New Drugs (in press).Google Scholar
- Lehmann, H. E., C. H. Cahn, and R. L. DeVerteuil: The treatment of depressive conditions with imipramine. Canad. psychiat. Ass. J. 3 (4), 155–164 (1958).Google Scholar
- Mann, A.: Desmethylimipramine in the treatment of depression: Pilot study in a general hospital and outpatient setting. Canad. med. Ass. J. 86, 495–598 (1962).Google Scholar
- Meduna, L. J., L. G. Abood, and J. H. Brel: (N(-Methylaminopropyl) Iminodibenzyl: A new antidepressant. J. Neuropsychiat. 2, 232–237 (1961).Google Scholar
- Oltman, J. E., and S. Friedman: Preliminary investigation of desmethylimipramine. Amer. J. Psychiat. 119 (4), 370–371 (1962).Google Scholar
- Pletscher, A., u. K. F. Gey: Pharmakologische Beeinflussung des 5-Hydroxytryptamine-Stoffwechsels im Gehirn und Monoaminoxydasehemmung in vitro. Helv. physiol. pharmacol. Acta 17, C 35 (1959).Google Scholar
- Poldinger, W.: Comparison between imipramine and desipramine in normal subjects and their actions in depressive patients. Psychopharmacologia (Berl.) 4, 302–307 (1963).Google Scholar
- Pollack, B.: Clinical findings in the use of Tofranil in depressives and other psychiatric states. Amer. J. Psychiat. 116, 312 (1959).Google Scholar
- Pulver, R., B. Exer u. B. Herrmann: Einige Wirkungen des N-(Dimethylaminopropyl)-iminodibenzyl-HCL und seiner Metabolite auf den Stoffwechsel von Neurohormonen. Arzneimittel-Forsch. 10, 530–533 (1960).Google Scholar
- Schaeppi, U.: Die Beeinflussung der Reizübertragung im peripheren Sympathicus durch Tofranil. Helv. physiol. pharmacol. Acta 18, 545–562 (1960).Google Scholar
- Sigg, E. B.: Pharmacological studies with Tofranil. Canad. Psychiat. Ass. J. 4, 75–83 (1959), Special Suppl.Google Scholar
- Stein, L., and J. Seifter: Possible model of antidepressive action of imipramine. Science 134 (3474), 286–287 (1961).Google Scholar
- Sulser, F., J. Watts, and B. B. Brodie: On the mechanism of antidepressant action of imipramine-like drugs. Ann. N.Y. Acad. Sci. 96, 279–288 (1962).Google Scholar